US Stock MarketDetailed Quotes

SGMT Sagimet Biosciences

Watchlist
  • 5.540
  • +0.370+7.16%
Close Nov 27 16:00 ET
  • 5.790
  • +0.250+4.51%
Post 20:01 ET
178.36MMarket Cap-4755P/E (TTM)

Sagimet Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
2M
0
2M
0
0
0
0
Operating revenue
--0
--0
--0
--2M
--0
--2M
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
78.82%16.9M
50.05%10.59M
29.61%8.77M
5.43%32.74M
28.13%9.47M
22.98%9.45M
-2.50%7.06M
-22.62%6.77M
30.93%31.06M
7.39M
Selling and administrative expenses
-5.45%4.25M
79.59%4.28M
53.91%3.51M
111.26%12.96M
147.24%3.81M
429.95%4.49M
174.63%2.38M
-20.90%2.28M
40.12%6.14M
--1.54M
-General and administrative expense
-5.45%4.25M
79.59%4.28M
53.91%3.51M
111.26%12.96M
147.24%3.81M
429.95%4.49M
174.63%2.38M
-20.90%2.28M
40.12%6.14M
--1.54M
Research and development costs
155.20%12.65M
35.01%6.31M
17.27%5.26M
-20.63%19.78M
-3.27%5.66M
-27.49%4.96M
-26.60%4.68M
-23.47%4.49M
28.85%24.92M
--5.85M
Operating profit
-126.81%-16.9M
-50.05%-10.59M
-29.61%-8.77M
1.01%-30.74M
-28.13%-9.47M
3.04%-7.45M
2.50%-7.06M
22.62%-6.77M
-30.93%-31.06M
-7.39M
Net non-operating interest income expense
108.49%2.28M
808.46%2.47M
1,088.33%2.14M
417.18%2.86M
580.83%1.31M
402.29%1.1M
100.00%272K
2,900.00%180K
2,026.92%553K
193K
Non-operating interest income
108.49%2.28M
808.46%2.47M
1,088.33%2.14M
417.18%2.86M
580.83%1.31M
402.29%1.1M
100.00%272K
2,900.00%180K
2,026.92%553K
--193K
Other net income (expense)
33.33%4K
1K
300.00%4K
-200.00%-2K
100.40%3K
0
Gain on sale of security
----
----
----
33.33%4K
--1K
300.00%4K
----
-200.00%-2K
100.40%3K
--0
Income before tax
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
8.60%-27.88M
-13.29%-8.15M
14.92%-6.35M
4.46%-6.79M
24.59%-6.59M
-24.78%-30.5M
-7.2M
Income tax
Net income
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
8.60%-27.88M
-13.29%-8.15M
14.92%-6.35M
4.46%-6.79M
24.59%-6.59M
-24.78%-30.5M
-7.2M
Net income continuous Operations
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
8.60%-27.88M
-13.29%-8.15M
14.92%-6.35M
4.46%-6.79M
24.59%-6.59M
-24.78%-30.5M
---7.2M
Minority interest income
Net income attributable to the parent company
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
8.60%-27.88M
-13.29%-8.15M
14.92%-6.35M
4.46%-6.79M
24.59%-6.59M
-24.78%-30.5M
-7.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
8.60%-27.88M
-13.29%-8.15M
14.92%-6.35M
4.46%-6.79M
24.59%-6.59M
-24.78%-30.5M
-7.2M
Basic earnings per share
-28.57%-0.45
18.30%-0.25
22.57%-0.23
-93.39%-2.66
-9.72%-0.356
-3.94%-0.35
4.46%-0.306
24.59%-0.2971
-24.78%-1.3754
-0.3245
Diluted earnings per share
-28.57%-0.45
18.30%-0.25
22.57%-0.23
-93.39%-2.66
-9.72%-0.356
-3.94%-0.35
4.46%-0.306
24.59%-0.2971
-24.78%-1.3754
-0.3245
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0002M02M0000
Operating revenue --0--0--0--2M--0--2M--0--0--0--0
Cost of revenue
Gross profit
Operating expense 78.82%16.9M50.05%10.59M29.61%8.77M5.43%32.74M28.13%9.47M22.98%9.45M-2.50%7.06M-22.62%6.77M30.93%31.06M7.39M
Selling and administrative expenses -5.45%4.25M79.59%4.28M53.91%3.51M111.26%12.96M147.24%3.81M429.95%4.49M174.63%2.38M-20.90%2.28M40.12%6.14M--1.54M
-General and administrative expense -5.45%4.25M79.59%4.28M53.91%3.51M111.26%12.96M147.24%3.81M429.95%4.49M174.63%2.38M-20.90%2.28M40.12%6.14M--1.54M
Research and development costs 155.20%12.65M35.01%6.31M17.27%5.26M-20.63%19.78M-3.27%5.66M-27.49%4.96M-26.60%4.68M-23.47%4.49M28.85%24.92M--5.85M
Operating profit -126.81%-16.9M-50.05%-10.59M-29.61%-8.77M1.01%-30.74M-28.13%-9.47M3.04%-7.45M2.50%-7.06M22.62%-6.77M-30.93%-31.06M-7.39M
Net non-operating interest income expense 108.49%2.28M808.46%2.47M1,088.33%2.14M417.18%2.86M580.83%1.31M402.29%1.1M100.00%272K2,900.00%180K2,026.92%553K193K
Non-operating interest income 108.49%2.28M808.46%2.47M1,088.33%2.14M417.18%2.86M580.83%1.31M402.29%1.1M100.00%272K2,900.00%180K2,026.92%553K--193K
Other net income (expense) 33.33%4K1K300.00%4K-200.00%-2K100.40%3K0
Gain on sale of security ------------33.33%4K--1K300.00%4K-----200.00%-2K100.40%3K--0
Income before tax -130.11%-14.62M-19.65%-8.12M-0.64%-6.63M8.60%-27.88M-13.29%-8.15M14.92%-6.35M4.46%-6.79M24.59%-6.59M-24.78%-30.5M-7.2M
Income tax
Net income -130.11%-14.62M-19.65%-8.12M-0.64%-6.63M8.60%-27.88M-13.29%-8.15M14.92%-6.35M4.46%-6.79M24.59%-6.59M-24.78%-30.5M-7.2M
Net income continuous Operations -130.11%-14.62M-19.65%-8.12M-0.64%-6.63M8.60%-27.88M-13.29%-8.15M14.92%-6.35M4.46%-6.79M24.59%-6.59M-24.78%-30.5M---7.2M
Minority interest income
Net income attributable to the parent company -130.11%-14.62M-19.65%-8.12M-0.64%-6.63M8.60%-27.88M-13.29%-8.15M14.92%-6.35M4.46%-6.79M24.59%-6.59M-24.78%-30.5M-7.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -130.11%-14.62M-19.65%-8.12M-0.64%-6.63M8.60%-27.88M-13.29%-8.15M14.92%-6.35M4.46%-6.79M24.59%-6.59M-24.78%-30.5M-7.2M
Basic earnings per share -28.57%-0.4518.30%-0.2522.57%-0.23-93.39%-2.66-9.72%-0.356-3.94%-0.354.46%-0.30624.59%-0.2971-24.78%-1.3754-0.3245
Diluted earnings per share -28.57%-0.4518.30%-0.2522.57%-0.23-93.39%-2.66-9.72%-0.356-3.94%-0.354.46%-0.30624.59%-0.2971-24.78%-1.3754-0.3245
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data